Atrium is planning to sell its active ingredients and
specialty chemicals division in order to focus its energies on the
nutritional supplements sector.
Atrium this week announced its full acquisition of active
ingredient supplier Siricie. The €1.6 million cash deal
demonstrates the trend of biotechnology companies moving further
towards novel products.